Skip to main content
Erschienen in: The International Journal of Cardiovascular Imaging 4/2015

01.04.2015 | Original Paper

Basal infarct location but not larger infarct size is associated with a successful outcome after alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy: a cardiovascular magnetic resonance imaging study

verfasst von: Robbert C. Steggerda, Christiane A. Geluk, Wessel Brouwer, Albert C. van Rossum, Jurriën M. ten Berg, Maarten P. van den Berg

Erschienen in: The International Journal of Cardiovascular Imaging | Ausgabe 4/2015

Einloggen, um Zugang zu erhalten

Abstract

Alcohol septal ablation (ASA) is successful in most but not in all patients with obstructive hypertrophic cardiomyopathy (HCM). We therefore sought to investigate the relation between infarct location versus infarct size with outcome after ASA in patients with obstructive HCM. Baseline characteristics, procedural characteristics, and cardiovascular magnetic resonance findings at baseline and 4–6 month follow-up after ASA were analysed in 47 patients with obstructive HCM in a single-center retrospective study. Infarct size was determined using late gadolinium enhancement. Infarct location was divided into “basal infarction” and “distal infarction” based on an optimal cut-of value of the distance from the basal septum to the beginning of the infarction. A “successful” outcome was defined as 80 % reduction of the invasive gradient with a post-procedural gradient of <10 mmHg. Basal infarctions (n = 31) compared to distal infarctions (n = 16) were associated with successful outcome (100 vs. 38 %, P < 0.001). Larger infarct size (n = 20) compared to smaller infarct size (n = 27) was not associated with successful outcome (75 vs. 82 %, P = 0.72). A more distal location of the infarction, was the only predictor of a less successful outcome (odds ratio 0.76, 95 % confidence interval 0.54–0.98, P = 0.03). Basal versus distal infarctions were also associated with a lower provoked gradient at late (2.6 ± 2.2 years) follow-up (11 (6–20) vs. 27 (12–94) mmHg, P = 0.01). Basal infarctions were associated with a successful outcome after ASA. A larger infarct size was not associated with a better outcome.
Literatur
2.
Zurück zum Zitat Ball W, Ivanov J, Rakowski H, Wigle ED, Linghorne M, Ralph-Edwards A, Williams WG, Schwartz L, Guttman A, Woo A (2011) Long-term survival in patients with resting obstructive hypertrophic cardiomyopathy comparison of conservative versus invasive treatment. J Am Coll Cardiol 58:2313–2321. doi:10.1016/j.jacc.2011.08.040 CrossRefPubMed Ball W, Ivanov J, Rakowski H, Wigle ED, Linghorne M, Ralph-Edwards A, Williams WG, Schwartz L, Guttman A, Woo A (2011) Long-term survival in patients with resting obstructive hypertrophic cardiomyopathy comparison of conservative versus invasive treatment. J Am Coll Cardiol 58:2313–2321. doi:10.​1016/​j.​jacc.​2011.​08.​040 CrossRefPubMed
5.
Zurück zum Zitat Leonardi RA, Kransdorf EP, Simel DL, Wang A (2010) Meta-analysis of septal reduction therapies for obstructive hypertrophic cardiomyopathy. Comparative rates of overall mortality and sudden cardiac death after treatment. Circ Cardiovasc Interv 3:1–7. doi:10.1161/CIRCINTERVENTIONS.109.916676 CrossRef Leonardi RA, Kransdorf EP, Simel DL, Wang A (2010) Meta-analysis of septal reduction therapies for obstructive hypertrophic cardiomyopathy. Comparative rates of overall mortality and sudden cardiac death after treatment. Circ Cardiovasc Interv 3:1–7. doi:10.​1161/​CIRCINTERVENTION​S.​109.​916676 CrossRef
7.
Zurück zum Zitat Jensen MK, Prinz C, Horsthotte D, van Beure F, Bitter T, Faber L, Bundgaard H (2013) Alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy: low incidence of sudden cardiac death and reduced risk profile. Heart 99(14):1012–1017. doi:10.1136/heartjnl-2012-303339 CrossRefPubMed Jensen MK, Prinz C, Horsthotte D, van Beure F, Bitter T, Faber L, Bundgaard H (2013) Alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy: low incidence of sudden cardiac death and reduced risk profile. Heart 99(14):1012–1017. doi:10.​1136/​heartjnl-2012-303339 CrossRefPubMed
8.
Zurück zum Zitat Nagueh SF, Groves BM, Schwartz L, Smith KM, Wang A, Bach RG, Nielsen C, Leya F, Buergler JM, Rowe SK, Woo A, Maldonado YM, Spencer WH 3rd (2011) Alcohol septal ablation for the treatment of hypertrophic obstructive cardiomyopathy. A multicenter North American registry. J Am Coll Cardiol 58:2322–2328. doi:10.1016/j.jacc.2011.06.073 CrossRefPubMed Nagueh SF, Groves BM, Schwartz L, Smith KM, Wang A, Bach RG, Nielsen C, Leya F, Buergler JM, Rowe SK, Woo A, Maldonado YM, Spencer WH 3rd (2011) Alcohol septal ablation for the treatment of hypertrophic obstructive cardiomyopathy. A multicenter North American registry. J Am Coll Cardiol 58:2322–2328. doi:10.​1016/​j.​jacc.​2011.​06.​073 CrossRefPubMed
9.
Zurück zum Zitat Valeti US, Nishimura RA, Holmes DR, Araoz PA, Glockner JF, Breen JF, Ommen SR, Gersh BJ, Tajik AJ, Rihal CS, Schaff HV, Maron BJ (2007) Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 49:350–357. doi:10.1016/j.jacc.2006.08.055 CrossRefPubMed Valeti US, Nishimura RA, Holmes DR, Araoz PA, Glockner JF, Breen JF, Ommen SR, Gersh BJ, Tajik AJ, Rihal CS, Schaff HV, Maron BJ (2007) Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 49:350–357. doi:10.​1016/​j.​jacc.​2006.​08.​055 CrossRefPubMed
12.
Zurück zum Zitat Veselka J, Procházková S, Duchonová R, Bomovolá-Homovolá I, Pálenícková J, Tesar D, Cervinka P, Honek T (2004) Alcohol septal ablation for hypertrophic obstructive cardiomyopathy. Lower alcohol dose reduces size of infarction and has comparable hemodynamic and clinical outcome. Cath Cardiovasc Interv 63(2):231–235. doi:10.1002/ccd.20176 CrossRef Veselka J, Procházková S, Duchonová R, Bomovolá-Homovolá I, Pálenícková J, Tesar D, Cervinka P, Honek T (2004) Alcohol septal ablation for hypertrophic obstructive cardiomyopathy. Lower alcohol dose reduces size of infarction and has comparable hemodynamic and clinical outcome. Cath Cardiovasc Interv 63(2):231–235. doi:10.​1002/​ccd.​20176 CrossRef
13.
Zurück zum Zitat Van der Lee C, Scholzel B, ten Berg JM, Geleijnse ML, Idzerda HH, van Domburg RT, Vletter WB, Serruys PW, ten Cate FJ (2008) Usefulness of clinical, echocardiographic, and procedural characteristics to predict outcome after percutaneous transluminal septal myocardial ablation. Am J Cardiol 101:1315–1320. doi:10.1016/j.amjcard.2008.01.003 CrossRefPubMed Van der Lee C, Scholzel B, ten Berg JM, Geleijnse ML, Idzerda HH, van Domburg RT, Vletter WB, Serruys PW, ten Cate FJ (2008) Usefulness of clinical, echocardiographic, and procedural characteristics to predict outcome after percutaneous transluminal septal myocardial ablation. Am J Cardiol 101:1315–1320. doi:10.​1016/​j.​amjcard.​2008.​01.​003 CrossRefPubMed
14.
Zurück zum Zitat Guarise A, Faccioli N, Foti G, Da Pozzo S, Meneghetti P, Morana G (2011) Role of echocardiography and cardiac MRI in depicting morphological and functional imaging findings useful for diagnosing hypertrophic cardiomyopathy. Radiol med 116:197–210. doi:10.1007/s11547 CrossRefPubMed Guarise A, Faccioli N, Foti G, Da Pozzo S, Meneghetti P, Morana G (2011) Role of echocardiography and cardiac MRI in depicting morphological and functional imaging findings useful for diagnosing hypertrophic cardiomyopathy. Radiol med 116:197–210. doi:10.​1007/​s11547 CrossRefPubMed
16.
Zurück zum Zitat van Dockum WG, ten Cate FJ, ten Berg JM, Beek AM, Twisk JW, Vos J, Hofman MB, Visser CA, van Rossum AC (2004) Myocardial infarction after percutaneus transluminal septal ablation in hypertrophic obstructive cardiomyopathy: evaluation by contrast-enhanced magnetic resonance imaging. J Am Coll Cardiol 43:24–27. doi:10.1016/j.jacc.2003.08.031 CrossRef van Dockum WG, ten Cate FJ, ten Berg JM, Beek AM, Twisk JW, Vos J, Hofman MB, Visser CA, van Rossum AC (2004) Myocardial infarction after percutaneus transluminal septal ablation in hypertrophic obstructive cardiomyopathy: evaluation by contrast-enhanced magnetic resonance imaging. J Am Coll Cardiol 43:24–27. doi:10.​1016/​j.​jacc.​2003.​08.​031 CrossRef
17.
Zurück zum Zitat van Dockum WG, Beek AM, ten Cate FJ, ten Berg JM, Bondarenko O, Götte MJ, Twisk JW, Hofman MB, Visser CA, van Rossum AC (2005) Early onset and progression of left ventricular remodeling after alcohol septal ablation in hypertrophic obstructive cardiomyopathy. Circulation 111:2503–2508. doi:10.1161/01.CIR.0000165084.28065.01 CrossRefPubMed van Dockum WG, Beek AM, ten Cate FJ, ten Berg JM, Bondarenko O, Götte MJ, Twisk JW, Hofman MB, Visser CA, van Rossum AC (2005) Early onset and progression of left ventricular remodeling after alcohol septal ablation in hypertrophic obstructive cardiomyopathy. Circulation 111:2503–2508. doi:10.​1161/​01.​CIR.​0000165084.​28065.​01 CrossRefPubMed
18.
19.
Zurück zum Zitat Berruezo A, Vatasescu R, Mont L, Sitges M, Perez D, Papishvilli G, Vidal B, Francino A, Fernández-Armenta J, Silva E, Bijnens B, González-Juanatey JR, Brugada J (2011) Biventricular pacing in hypertrophic obstructive cardiomyopathy: a pilot study. Heart Rhythm 8:221–227. doi:10.1016/j.hrthm.2010.10.010 CrossRefPubMed Berruezo A, Vatasescu R, Mont L, Sitges M, Perez D, Papishvilli G, Vidal B, Francino A, Fernández-Armenta J, Silva E, Bijnens B, González-Juanatey JR, Brugada J (2011) Biventricular pacing in hypertrophic obstructive cardiomyopathy: a pilot study. Heart Rhythm 8:221–227. doi:10.​1016/​j.​hrthm.​2010.​10.​010 CrossRefPubMed
20.
Zurück zum Zitat Steggerda RC, Balt JC, Damman K, van den Berg MP, ten Berg JM (2013) Predictors of outcome after alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy. Special interest for the septal coronary anatomy. Neth Heart J 21(11):504–509. doi:10.1007/s12471-013-0453-4 CrossRefPubMedCentralPubMed Steggerda RC, Balt JC, Damman K, van den Berg MP, ten Berg JM (2013) Predictors of outcome after alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy. Special interest for the septal coronary anatomy. Neth Heart J 21(11):504–509. doi:10.​1007/​s12471-013-0453-4 CrossRefPubMedCentralPubMed
Metadaten
Titel
Basal infarct location but not larger infarct size is associated with a successful outcome after alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy: a cardiovascular magnetic resonance imaging study
verfasst von
Robbert C. Steggerda
Christiane A. Geluk
Wessel Brouwer
Albert C. van Rossum
Jurriën M. ten Berg
Maarten P. van den Berg
Publikationsdatum
01.04.2015
Verlag
Springer Netherlands
Erschienen in
The International Journal of Cardiovascular Imaging / Ausgabe 4/2015
Print ISSN: 1569-5794
Elektronische ISSN: 1875-8312
DOI
https://doi.org/10.1007/s10554-015-0606-1

Weitere Artikel der Ausgabe 4/2015

The International Journal of Cardiovascular Imaging 4/2015 Zur Ausgabe

Das Risiko für Vorhofflimmern in der Bevölkerung steigt

02.05.2024 Vorhofflimmern Nachrichten

Das Risiko, im Lauf des Lebens an Vorhofflimmern zu erkranken, ist in den vergangenen 20 Jahren gestiegen: Laut dänischen Zahlen wird es drei von zehn Personen treffen. Das hat Folgen weit über die Schlaganfallgefährdung hinaus.

VHF-Ablation nützt wohl nur bei reduzierter Auswurfleistung

02.05.2024 Ablationstherapie Nachrichten

Ob die Katheterablation von Vorhofflimmern bei Patienten mit Herzinsuffizienz die Komplikationsraten senkt, scheint davon abzuhängen, ob die Auswurfleistung erhalten ist oder nicht. Das legen die Ergebnisse einer Metaanalyse nahe.

Weniger Extremitätenischämien mit dualer Plättchenhemmung

02.05.2024 Thrombozytenaggregationshemmer Nachrichten

Eine Behandlung mit Ticagrelor zusätzlich zu ASS kann das Risiko für Revaskularisierungen und Amputationen von Extremitäten bei Diabetikern mit stabiler KHK deutlich reduzieren, vor allem für solche mit PAVK. Dafür spricht eine Auswertung der Interventionsstudie THEMIS.

Beutel versus Maschine: Beste Beatmungstechnik bei Herzstillstand gesucht

02.05.2024 Kardiopulmonale Reanimation Nachrichten

Stehen die Chancen auf eine Rückkehr der Spontanzirkulation nach Herz-Kreislauf-Stillstand bei manueller oder maschineller Beatmung besser? Und unterscheidet sich das neurologische Outcome nach der Reanimation? Das belgische Herzstillstand-Register liefert die Daten für einen direkten Vergleich zwischen Beutel und Beatmungsgerät.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.